<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">451</article-id>
<article-id pub-id-type="doi">10.54660/IJMBHR.2026.7.1.165-170</article-id>
<title-group><article-title>A narrative Review about Common Complications of Type 1 Diabetes</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Hamza</surname><given-names>Alaa Talib</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<aff id="aff1"><label>1</label>Department of Basic Science, College of Dentistry, University of AL-Qadisiyah, AL-Diwaniyah, Iraq</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><day>06</day><month>02</month><year>2026</year></pub-date>
<volume>7</volume>
<issue>1</issue>
<fpage>165</fpage>
<lpage>170</lpage>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/451/a-narrative-review-about-common-complications-of-type-1-diabetes"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/451/download"/>
<abstract><p>Type 1 diabetes (T1D), or insulin-dependent diabetes, is a persistent autoimmune problem and a type of diabetes in which insulin levels are low on account to the demolition of pancreatic beta cells. It is one of the most common health problems of our time. Although blood glucose levels can be controlled, there is a risk of complications that can have a negative impact on daily life. This review aims to list and summarize the common complications of this disease that occur after infection, as they require continuous monitoring and fruitful management strategies. Health care providers should have a comprehensive and organized program that includes ongoing and organized testing of patients, educational support, psychological support for the patient, and improving glucose control as a basic requirement for maintaining general health and reducing complications.</p></abstract>
<kwd-group kwd-group-type="author"><kwd>Insulin</kwd><kwd>Beta cell</kwd><kwd>Glucose</kwd><kwd>Type1 Diabetes</kwd><kwd>Complication</kwd><kwd>Autoimmune diseases</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Kahanovitz L, Sluss PM, Russell SJ. Type 1 diabetes – a clinical perspective. Point Care. 2017;16(1):37-40. doi:10.1097/POC.0000000000000125.</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Chiang JL, Kirkman MS, Laffel LMB, Peters AL; Type 1 Diabetes Sourcebook Authors. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014;37(7):2034-2054. doi:10.2337/dc14-1140.</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Boscari F, Avogaro A. Current treatment options and challenges in patients with type 1 diabetes: pharmacological, technical advances and future perspectives. Rev Endocr Metab Disord. 2021;22(2):217-240. doi:10.1007/s11154-021-09635-3.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Chamine I, Hwang J, Valenzuela S, Marino M, Larson AE, Georgescu J, et al. Acute and chronic diabetes-related complications among patients with diabetes receiving care in community health centers. Diabetes Care. 2022;45(10):e141-e143. doi:10.2337/dc22-0420.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab. 2008;93(5):1541-1552. doi:10.1210/jc.2007-2577.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>El-Remessy AB. Diabetic ketoacidosis management: updates and challenges for specific patient population. Endocrines. 2022;3:801 -812. doi:10.3390/endocrines3040066.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Umpierrez GE, Davis GM, ElSayed NA, Fadini GP, Galindo RJ, Hirsch IB, et al. Hyperglycemic crises in adults with diabetes: a consensus report. Diabetes Care. 2024;47(8):1257-1275. doi:10.2337/dci24-0032.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335 -1343. doi:10.2337/dc09-9032.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Li S, Xiao X, Zhang X. Hydration status in older adults: current knowledge and future challenges. Nutrients. 2023;15(11):2609. doi:10.3390/nu15112609.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Hassan EM, Mushtaq H, Mahmoud EE, Chhibber S, Saleem S, Issa A, et al. Overlap of diabetic ketoacidosis and hyperosmolar hyperglycemic state. World J Clin Cases. 2022;10(32):11702 -11711. doi:10.12998/wjcc.v10.i32.11702.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Khin PP, Lee JH, Jun HS. Pancreatic beta-cell dysfunction in type 2 diabetes. Eur J Inflamm. 2023;21:1721727X231154152. doi:10.1177/1721727X231154152.</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Chipkin SR, Klugh SA, Chasan-Taber L. Exercise and diabetes. Cardiol Clin. 2001;19(3):489-505. doi:10.1016/S0733-8651(05)70231-9.</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Lowe RN, Williams B, Claus LW. Diabetes: how to International Journal of Medical and All Body Health Research www.allmedicaljournal.com manage patients experiencing hypoglycaemia. Drugs Context. 2022;11:2021-9-11. doi:10.7573/dic.2021-9-11.</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Martín-Timón I, Del Cañizo-Gómez FJ. Mechanisms of hypoglycemia unawareness and implications in diabetic patients. World J Diabetes. 2015;6(7):912-926. doi:10.4239/wjd.v6.i7.912.</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Awoniyi O, Rehman R, Dagogo-Jack S. Hypoglycemia in patients with type 1 diabetes: epidemiology, pathogenesis, and prevention. Curr Diab Rep. 2013;13:669-678. doi:10.1007/s11892-013-0411-y.</mixed-citation></ref>
<ref id="R16"><label>16</label><mixed-citation>Jacobson AM, Braffett BH, Cleary PA, Gubitosi-Klug RA, Larkin ME; DCCT/EDIC Research Group. The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the DCCT/EDIC cohort. Diabetes Care. 2013;36(10):3131-3138. doi:10.2337/dc12-2109.</mixed-citation></ref>
<ref id="R17"><label>17</label><mixed-citation>Shah VN, Bailey R, Wu M, Foster NC, Pop-Busui R, Katz M, et al. Risk factors for cardiovascular disease in adults with type 1 diabetes: findings from the T1D Exchange Registry. J Clin Endocrinol Metab. 2020;105(5):e2032-e2038. doi:10.1210/clinem/dgaa015.</mixed-citation></ref>
<ref id="R18"><label>18</label><mixed-citation>Higashi Y. Roles of oxidative stress and inflammation in vascular endothelial dysfunction-related disease. Antioxidants (Basel). 2022;11(10):1958. doi:10.3390/antiox11101958.</mixed-citation></ref>
<ref id="R19"><label>19</label><mixed-citation>Ahuja A, Agrawal S, Acharya S, Reddy V, Batra N. Strategies for cardiovascular disease prevention in type 1 diabetes: a comprehensive review. Cureus. 2024;16(8):e66420. doi:10.7759/cureus.66420.</mixed-citation></ref>
<ref id="R20"><label>20</label><mixed-citation>Vergès B. Cardiovascular disease in type 1 diabetes, an underestimated danger: epidemiological and pathophysiological data. Atherosclerosis. 2024;394:117158. doi:10.1016/j.atherosclerosis.2023.06.005.</mixed-citation></ref>
<ref id="R21"><label>21</label><mixed-citation>Bjornstad P, Cherney D, Maahs DM. Early diabetic nephropathy in type 1 diabetes: new insights. Curr Opin Endocrinol Diabetes Obes. 2014;21(4):279-286. doi:10.1097/MED.0000000000000074.</mixed-citation></ref>
<ref id="R22"><label>22</label><mixed-citation>Shilpasree AS, Patil VS, Revanasiddappa M, Patil VP, Ireshnavar D. Renal dysfunction in prediabetes: confirmed by glomerular hyperfiltration and albuminuria. J Lab Physicians. 2021;13(3):257-262. doi:10.1055/s-0041-1731107.</mixed-citation></ref>
<ref id="R23"><label>23</label><mixed-citation>Opsahl JA, Abraham PA, Keane WF. Angiotensin-converting enzyme inhibitors in chronic renal failure. Drugs. 1990;39 Suppl 2:23-32. doi:10.2165/00003495-199000392-00006.</mixed-citation></ref>
<ref id="R24"><label>24</label><mixed-citation>Popovic DS, Patoulias D, Gnudi L, Mantzoros CS. Diabetic kidney disease in type 1 diabetes: challenges and differences from type 2 diabetes. Metabolism. 2024;151:155763. doi:10.1016/j.metabol.2023.155763.</mixed-citation></ref>
<ref id="R25"><label>25</label><mixed-citation>Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo TKS, et al. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation. EPMA J. 2023;14(1):21-42. doi:10.1007/s13167-023-00314-8.</mixed-citation></ref>
<ref id="R26"><label>26</label><mixed-citation>Kollias AN, Ulbig MW. Diabetic retinopathy: early diagnosis and effective treatment. Dtsch Arztebl Int. 2010;107(5):75-83. doi:10.3238/arztebl.2010.0075.</mixed-citation></ref>
<ref id="R27"><label>27</label><mixed-citation>Pandya M, Banait S, Daigavane S. Insights into visual rehabilitation: pan-retinal photocoagulation for proliferative diabetic retinopathy. Cureus. 2024;16(2):e54273. doi:10.7759/cureus.54273.</mixed-citation></ref>
<ref id="R28"><label>28</label><mixed-citation>Yue T, Shi Y, Luo S, Weng J, Wu Y, Zheng X. The role of inflammation in immune system of diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications. Front Immunol. 2022;13:1055087. doi:10.3389/fimmu.2022.1055087.</mixed-citation></ref>
<ref id="R29"><label>29</label><mixed-citation>Freeman R. Autonomic peripheral neuropathy. Lancet. 2005;365(9466):1259-1270. doi:10.1016/S0140-6736(05)74815-7.</mixed-citation></ref>
<ref id="R30"><label>30</label><mixed-citation>Spagnoli C, Pisani F, Di Mario F, Leandro G, Gaiani F, De&apos; Angelis GL, et al. Peripheral neuropathy and gastroenterologic disorders: an overview on an underrecognized association. Acta Biomed. 2018;89(9 Suppl):22-32. doi:10.23750/abmv89i9-S.7956.</mixed-citation></ref>
<ref id="R31"><label>31</label><mixed-citation>Alexiadou K, Doupis J. Management of diabetic foot ulcers. Diabetes Ther. 2012;3(1):4. doi:10.1007/s13300-012-0004-9.</mixed-citation></ref>
<ref id="R32"><label>32</label><mixed-citation>Muthulingam JA, Brock C, Hansen TM, Drewes AM, Brock B, Frøkjær JB. Disrupted white matter integrity in the brain of type 1 diabetes is associated with peripheral neuropathy and abnormal brain metabolites. J Diabetes Complications. 2022;36(9):108267. doi:10.1016/j.jdiacomp.2022.108267.</mixed-citation></ref>
<ref id="R33"><label>33</label><mixed-citation>Sugandh F, Chandio M, Raveena F, Kumar L, Karishma F, Khuwaja S, et al. Advances in the management of diabetes mellitus: a focus on personalized medicine. Cureus. 2023;15(8):e43697. doi:10.7759/cureus.43697.</mixed-citation></ref>
<ref id="R34"><label>34</label><mixed-citation>de Wit M, Gajewska KA, Goethals ER, McDarby V, Zhao X, Hapunda G, et al. ISPAD clinical practice consensus guidelines 2022: psychological care of children, adolescents and young adults with diabetes. Pediatr Diabetes. 2022;23(8):1373 -1389. doi:10.1111/pedi.13428.</mixed-citation></ref>
<ref id="R35"><label>35</label><mixed-citation>Russo K. Assessment and treatment of adolescents with chronic medical conditions. J Health Serv Psychol. 2022;48(2):69-78. doi:10.1007/s42843-022-00059-4.</mixed-citation></ref>
<ref id="R36"><label>36</label><mixed-citation>Joo JH, Bone L, Forte J, Kirley E, Lynch T, Aboumatar H. The benefits and challenges of established peer support programmes for patients, informal caregivers, and healthcare providers. Fam Pract. 2022;39(5):903-912. doi:10.1093/fampra/cmac004.</mixed-citation></ref>
<ref id="R37"><label>37</label><mixed-citation>Bombaci B, Torre A, Longo A, Pecoraro M, Papa M, Sorrenti L, et al. Psychological and clinical challenges in the management of type 1 diabetes during adolescence: a narrative review. Children (Basel). 2024;11(9):1085. doi:10.3390/children11091085.</mixed-citation></ref>
</ref-list></back>
</article>